Michael C. Puckette

发表

Evaluation of Gaussia luciferase and foot-and-mouth disease virus 2A translational interrupter chimeras as polycistronic reporters for transgene expression

T. Burrage, Michael C. Puckette, J. Neilan, 2017, BMC Biotechnology.

Generation and characterization of genetically stable heterohybridomas producing foot-and-mouth disease virus-specific porcine monoclonal antibodies.

W. Hurtle, Michael C. Puckette, J. Neilan, 2020, Journal of immunological methods.

Mechanisms of Foot-and-Mouth Disease Virus Tropism Inferred from Differential Tissue Gene Expression

J. Pacheco, J. Arzt, G. Smoliga, 2013, PloS one.

Comparative Evaluation of the Foot-and-Mouth Disease Virus Permissive LF-BK αVβ6 Cell Line for Senecavirus A Research

W. Hurtle, J. Mason, Michael C. Puckette, 2022, Viruses.

A colorimetric bioassay for high-throughput and cost-effectively assessing anti-foot-and-mouth disease virus activity.

M. Grubman, E. Bishop, Luis L. Rodriguez, 2015, Veterinary immunology and immunopathology.

Effect of foot-and-mouth disease virus 3C protease B2 β-strand proline mutagenesis on expression and processing of the P1 polypeptide using a plasmid expression vector.

Michael C. Puckette, J. Neilan, R. Kurker, 2019, The Journal of general virology.

Production of foot-and-mouth disease virus capsid proteins by the TEV protease.

Justin D. Smith, Michael C. Puckette, J. Neilan, 2018, Journal of biotechnology.

Detection of African swine fever virus utilizing the portable MatMaCorp ASF detection system

Michael C. Puckette, J. Neilan, J. Barrera, 2021, Transboundary and emerging diseases.

Transiently Transfected Mammalian Cell Cultures: An Adaptable and Effective Platform for Virus-like Particle-Based Vaccines against Foot-and-Mouth Disease Virus

W. Hurtle, Michael C. Puckette, J. Neilan, 2022, Viruses.

Foot-and-Mouth Disease (FMD) Virus 3C Protease Mutant L127P: Implications for FMD Vaccine Development

W. Hurtle, J. Pacheco, Justin D. Smith, 2017, Journal of Virology.

Evaluation of modified Vaccinia Ankara-based vaccines against foot-and-mouth disease serotype A24 in cattle.

W. Hurtle, Michael C. Puckette, J. Neilan, 2019, Vaccine.

Method for quantification of porcine type I interferon activity using luminescence, by direct and indirect means

Michael C. Puckette, M. Rasmussen, J. Barrera, 2022, BMC Biotechnology.

Evaluation of DNA Vaccine Candidates against Foot-and-Mouth Disease Virus in Cattle

Max Baagøe Rasmussen, Michael C. Puckette, J. Neilan, 2023, Vaccines.